The image shows the compound Tat-P4-(C5)2 after an injection into the spinal cord. The compound (purple) penetrates the nerve cells of the spinal cord (yellow), but not the surrounding cells (the cell nuclei are blue). Credit: University of Copenhagen.
Researchers from the University of Copenhagen have developed a new way to treat chronic pain which has been tested in mice. With a compound designed and developed by the researchers themselves, they can achieve complete pain relief.
Between seven and ten percent of the world’s population suffers from chronic pain originating from nerves that have been damaged. A disease that can be severely debilitating. Now, researchers from the University of Copenhagen have found a new way to treat the pain.
The treatment has been tested in mice, and the new results have been published in the scientific journal EMBO Molecular Medicine. For more than a decade, the researchers have been working to design, develop and test a drug that shall provide complete pain relief.
“We have developed a new way to treat chronic pain. It is a targeted treatment. That is, it does not affect the general neuronal signalling, but only affects the nerve changes that are caused by the disease,” says co-author Kenneth Lindegaard Madsen, Associate Professor at the Department of Neuroscience, University of Copenhagen.
“We have been working on this for more than ten years. We have taken the process all the way from understanding the biology, inventing and designing the compound to describing how it works in animals, affects their behaviour and removes the pain,” says Kenneth Lindegaard Madsen.
Chronic pain can occur, among other things, after surgery, in people with diabetes, after a blood clot and after an amputation in the form of phantom pain.
Clinical trials as the next step
The compound developed by the researchers is a so-called peptide named Tat-P4-(C5)2. The peptide is targeted and only affects the nerve changes that pose a problem and cause the pain.
In a previous study, the researchers have shown in an animal model that use of the peptide can also reduce addiction. Therefore, the researchers hope that the compound may potentially help pain patients who have become addicted to, for example, opioid pain relievers in particular.
“The compound works very efficiently, and we do not see any side effects. We can administer this peptide and obtain complete pain relief in the mouse model we have used, without the lethargic effect that characterises existing pain-relieving drugs,” says Kenneth Lindegaard Madsen, adding:
“Now, our next step is to work towards testing the treatment on people. The goal, for us, is to develop a drug, therefore the plan is to establish a biotech company as soon as possible so we can focus on this.”
The researchers are now working towards clinical trials in collaboration with, among others, pain researcher Nanna Brix Finnerup, Professor at Aarhus University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Study suggests digital apps can help chronic pain suffererson March 4, 2021 at 8:12 pm
Health apps have become a popular tool to track fitness, weight loss, sleep, and even menstrual cycles, and now another benefit of using digital applications has come to light.
- Digital app can help chronic pain sufferers manage their painon March 4, 2021 at 9:29 am
For the first time, an app has been shown to reduce key symptoms of chronic pain. A UHN-led study evaluated the impact of Manage My Pain (MMP), a digital health solution developed by ManagingLife, on ...
- Scientists find new cell type implicated in chronic pain, inflammationon March 4, 2021 at 8:01 am
One of the hallmarks of chronic pain is inflammation, and scientists at the UNC School of Medicine have discovered that anti-inflammatory cells called MRC1+ macrophages are dysfunctional in an animal ...
- What Chronic Pain Has Taught Me About Communicating With My Husbandon March 2, 2021 at 10:42 pm
The writer describes how she has learned good methods to communicate with her husband and family about getting housework done, since as someone with chronic pain, chores are often difficult for her to ...
- Study: The pandemic has worsened the condition of 70% of people with chronic painon March 2, 2021 at 5:49 pm
The pandemic has impacted significantly on people who suffer chronic pain. A study performed by the eHealth Lab, a research group affiliated with the Faculty of Health Sciences and the Universitat ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Complete pain relief
- Out There: After the pain, the toe must go onon March 4, 2021 at 1:00 pm
Your kind words and your own tales of toe jamming … maybe that’s not the right phrase … has helped ease the pain of my own near-fatal stubbing. For example, Christine, who was kind enough to send a ...
- FDA Clears Neuromodulation Device for Acute Migraine Painon March 2, 2021 at 9:46 am
Relivion is an adjustable headset that delivers modulated pulses of electric current through adaptive output channels around the head to six branches of the occipital and trigeminal nerves.
- Joint Paint Specialist In San Jose CA Helps A Client Stop Shoulder Pain In One Sessionon March 2, 2021 at 7:49 am
Scott Lamb, is a joint pain specialist in San Jose, CA. Scott Lamb has helped many clients find relief from chronic shoulder pain. Shoulder pain and injury is common in athletes and weight training.
- Global Pain Relief Patches Market 2020 Industry Growth, Top Players, Segmentation and Forecast to 2025on March 1, 2021 at 9:46 pm
MarketsandResearch.biz has published a report titled Global Pain Relief Patches Market Growth 2020-2025 that supplies an in-depth overview of the market with the help of market-related details. The ...
- Relationships between disaccharidase deficiencies, duodenal inflammation and symptom profile in children with abdominal painon March 1, 2021 at 9:23 am
Abdominal pain has been associated with. While relationships with individual symptoms have been assessed, relationships between disaccharidase deficien ...